Advertisement
Chimerix, Inc.

Chimerix, Inc. (CMRX) Stock Overview

Explore Chimerix, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CMRXNASDAQ
HealthcareBiotechnology
$8.54
$0.00(0.00%)
U.S. Market opens in 52h 20m
Advertisement

Chimerix, Inc. (CMRX)

Meyka AI Score

Z

Key Financials

Market Cap801.1M
P/E Ratio-8.67
EPS (TTM)$-0.99
ROE-0.56%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

CMRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Chimerix, Inc. (CMRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.67 and a market capitalization of 801.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
65.83%
6-Month Change
834.66%
Year-to-Date (YTD) Change
151.92%
1-Year Change
775.90%
3-Year Change
263.40%
5-Year Change
153.41%
All-Time (Max) Change
-54.55%

Contact Information

919 806 1074
2505 Meridian Parkway, Durham, NC, 27713

Company Facts

790 Employees
IPO DateApr 11, 2013
CountryUS

Frequently Asked Questions